CN102618505B - 人轮状病毒毒种ztr-68毒株及其分离,培养与鉴定 - Google Patents
人轮状病毒毒种ztr-68毒株及其分离,培养与鉴定 Download PDFInfo
- Publication number
- CN102618505B CN102618505B CN 201210077653 CN201210077653A CN102618505B CN 102618505 B CN102618505 B CN 102618505B CN 201210077653 CN201210077653 CN 201210077653 CN 201210077653 A CN201210077653 A CN 201210077653A CN 102618505 B CN102618505 B CN 102618505B
- Authority
- CN
- China
- Prior art keywords
- cell
- virus
- rotavirus
- strain
- ztr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000702690 Human rotavirus A Species 0.000 title abstract 4
- 238000002955 isolation Methods 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 claims abstract description 92
- 241000702670 Rotavirus Species 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 23
- 241000617996 Human rotavirus Species 0.000 claims abstract description 14
- 238000004321 preservation Methods 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 54
- 210000002966 serum Anatomy 0.000 claims description 38
- 238000010790 dilution Methods 0.000 claims description 35
- 239000012895 dilution Substances 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 31
- 210000003501 vero cell Anatomy 0.000 claims description 23
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 238000011218 seed culture Methods 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 20
- 244000309466 calf Species 0.000 claims description 17
- 230000003612 virological effect Effects 0.000 claims description 16
- 239000002609 medium Substances 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 14
- 239000010410 layer Substances 0.000 claims description 13
- 230000029087 digestion Effects 0.000 claims description 12
- 238000011081 inoculation Methods 0.000 claims description 11
- 238000012423 maintenance Methods 0.000 claims description 11
- 238000003757 reverse transcription PCR Methods 0.000 claims description 10
- 239000013553 cell monolayer Substances 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 230000007170 pathology Effects 0.000 claims description 9
- 238000010839 reverse transcription Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 241000700199 Cavia porcellus Species 0.000 claims description 6
- 206010012735 Diarrhoea Diseases 0.000 claims description 6
- 230000006978 adaptation Effects 0.000 claims description 6
- 239000002299 complementary DNA Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 238000013207 serial dilution Methods 0.000 claims description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- 238000002474 experimental method Methods 0.000 claims description 5
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 5
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000002953 anti-rotaviral effect Effects 0.000 claims description 4
- 239000008098 formaldehyde solution Substances 0.000 claims description 4
- 238000003306 harvesting Methods 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 108091035707 Consensus sequence Proteins 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 231100000645 Reed–Muench method Toxicity 0.000 claims description 3
- 241001247927 Rotavirus G1 Species 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 238000001502 gel electrophoresis Methods 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 238000003384 imaging method Methods 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 230000011218 segmentation Effects 0.000 claims description 3
- 238000012772 sequence design Methods 0.000 claims description 3
- 238000012163 sequencing technique Methods 0.000 claims description 3
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 3
- 239000002356 single layer Substances 0.000 claims description 3
- 238000004448 titration Methods 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 2
- 239000002054 inoculum Substances 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 241001137860 Rotavirus A Species 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 abstract description 13
- 230000002238 attenuated effect Effects 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 230000002068 genetic effect Effects 0.000 abstract description 2
- 229940126578 oral vaccine Drugs 0.000 abstract description 2
- 230000029812 viral genome replication Effects 0.000 abstract description 2
- 238000009629 microbiological culture Methods 0.000 abstract 1
- 230000009849 deactivation Effects 0.000 description 15
- 229940124859 Rotavirus vaccine Drugs 0.000 description 11
- 238000000926 separation method Methods 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 7
- 230000036039 immunity Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 206010067470 Rotavirus infection Diseases 0.000 description 5
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Inorganic materials [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- 208000019637 Infantile Diarrhea Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000010166 immunofluorescence Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000000432 density-gradient centrifugation Methods 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000011330 nucleic acid test Methods 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000011146 sterile filtration Methods 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical class OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102100038284 Cytospin-B Human genes 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000032754 Infant Death Diseases 0.000 description 1
- 208000005168 Intussusception Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000204003 Mycoplasmatales Species 0.000 description 1
- 101710138767 Non-structural glycoprotein 4 Proteins 0.000 description 1
- 101710144127 Non-structural protein 1 Proteins 0.000 description 1
- 101710144111 Non-structural protein 3 Proteins 0.000 description 1
- 101710144121 Non-structural protein 5 Proteins 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102100031776 SH2 domain-containing protein 3A Human genes 0.000 description 1
- 102100021798 SH2 domain-containing protein 3C Human genes 0.000 description 1
- 102100031056 Serine protease 57 Human genes 0.000 description 1
- 101710197596 Serine protease 57 Proteins 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210077653 CN102618505B (zh) | 2012-03-22 | 2012-03-22 | 人轮状病毒毒种ztr-68毒株及其分离,培养与鉴定 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210077653 CN102618505B (zh) | 2012-03-22 | 2012-03-22 | 人轮状病毒毒种ztr-68毒株及其分离,培养与鉴定 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102618505A CN102618505A (zh) | 2012-08-01 |
CN102618505B true CN102618505B (zh) | 2013-07-10 |
Family
ID=46558717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210077653 Expired - Fee Related CN102618505B (zh) | 2012-03-22 | 2012-03-22 | 人轮状病毒毒种ztr-68毒株及其分离,培养与鉴定 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102618505B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103255235B (zh) * | 2013-05-27 | 2015-04-22 | 四川农业大学 | 大熊猫源轮状病毒CH-1株的Real-time PCR非诊断性检测方法 |
CN106916791B (zh) * | 2015-12-25 | 2021-05-04 | 中国医学科学院医学生物学研究所 | 人轮状病毒毒种ztr-18毒株及其分离,培养及鉴定 |
CN109536460A (zh) * | 2018-12-07 | 2019-03-29 | 中国医学科学院医学生物学研究所 | 一种cv-a10病毒毒种及其人用灭活疫苗 |
CN113151596B (zh) * | 2021-04-02 | 2023-08-08 | 中国医学科学院医学生物学研究所 | 一种四级生物安全实验室病毒化学淋浴消毒验证方法 |
CN113186170B (zh) * | 2021-05-26 | 2022-08-23 | 西南民族大学 | 一株猪轮状病毒株及其制备的灭活疫苗和用途 |
CN114469996B (zh) * | 2021-12-23 | 2023-10-20 | 中国医学科学院医学生物学研究所 | 一种包含miR-135b-5p的外泌体及在抗轮状病毒感染中的应用 |
-
2012
- 2012-03-22 CN CN 201210077653 patent/CN102618505B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102618505A (zh) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102618505B (zh) | 人轮状病毒毒种ztr-68毒株及其分离,培养与鉴定 | |
CN103031258B (zh) | 新的猪肺炎支原体菌株及其疫苗组合物 | |
CN107184969A (zh) | 一种a型赛尼卡谷病毒灭活疫苗及其制备方法和应用 | |
CN104099301B (zh) | 柯萨奇病毒a16型病毒株、用途、疫苗及其制备方法 | |
CN114854697B (zh) | 一种猪轮状病毒g4-g5-g9型三价灭活疫苗及其制备方法和用途 | |
CN102618506A (zh) | 人轮状病毒毒株及其分离,培养与鉴定方法 | |
CN106591242A (zh) | 一株犬细小病毒毒株cpv‑yh及其应用 | |
CN102363769B (zh) | 鸡马立克氏病毒Meq基因缺失疫苗株,其构建方法及应用 | |
CN102352347A (zh) | Pcv2重组杆状病毒构建及其亚单位疫苗制备方法 | |
CN104928260A (zh) | 一种牛传染性鼻气管炎病毒ibrv-jn03分离株及其应用 | |
CN102533671B (zh) | 一种柯萨奇病毒a16型病毒株及其应用 | |
CN114525261B (zh) | 一种猪流行性腹泻、猪轮状病毒二联灭活疫苗及其制备方法 | |
CN102787100A (zh) | 一种高繁殖能力猪圆环病毒2型毒株及其应用 | |
CN105396129B (zh) | 一种利用脊髓灰质炎减毒株生产的灭活疫苗 | |
CN101914502B (zh) | Ⅰ型犬腺病毒弱毒疫苗株及其应用 | |
CN102559606B (zh) | 一种柯萨奇病毒a16型病毒株及其应用 | |
CN104450559A (zh) | 新的猪肺炎支原体菌株及其疫苗组合物 | |
CN104371980A (zh) | 一种Sabin株脊髓灰质炎III型病毒单克隆抗体及其应用 | |
CN103087994B (zh) | 一种柯萨奇病毒a16型病毒株及其应用 | |
CN110305852A (zh) | 表达猪流行性腹泻病毒s1基因重组伪狂犬病病毒的构建 | |
CN109609467A (zh) | 一种cv-a6病毒毒种及其人用灭活疫苗 | |
CN102961742A (zh) | 猪圆环病毒2型与猪细小病毒二联灭活疫苗及其制备方法 | |
CN103160475A (zh) | 一种肠道病毒71型病毒株及其用途、疫苗和制备方法 | |
CN107137705B (zh) | 猪伪狂犬gE基因缺失病毒灭活疫苗的生产方法 | |
CN102174477B (zh) | 甲型肝炎病毒株sh及其二倍体细胞适应方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Hongjun Inventor after: Sun Maosheng Inventor after: Yi Shan Inventor after: Zhang Guangming Inventor after: Wu Jinyuan Inventor before: Li Hongjun Inventor before: Sun Maosheng Inventor before: Yi Shan Inventor before: Zhang Guangming Inventor before: Wu Jinyuan |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130710 |